The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 20.74 | 0.18 | +0.88% |
Saratoga Health & Biotechnology A | |||
GCIEX | 8.91 | 0.07 | +0.79% |
Gabelli Equity Income I | |||
FETKX | 29.41 | 0.20 | +0.68% |
Fidelity Equity Dividend Income K | |||
FWOMX | 16.47 | -0.04 | -0.24% |
Fidelity Women's Leadership | |||
GTDIX | 32.27 | -0.14 | -0.43% |
Invesco EQV Emerging Markets All Cap R5 |
A.I.dvisor indicates that over the last year, VIMCX has been closely correlated with FSMAX. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if VIMCX jumps, then FSMAX could also see price increases.
Ticker / NAME | Correlation To VIMCX | 1D Price Change % | ||
---|---|---|---|---|
VIMCX | 100% | N/A | ||
FSMAX - VIMCX | 89% Closely correlated | +1.07% | ||
RPTIX - VIMCX | 32% Poorly correlated | +0.53% | ||
PAMCX - VIMCX | 32% Poorly correlated | +0.53% | ||
RPMGX - VIMCX | 32% Poorly correlated | +0.53% | ||
RRMGX - VIMCX | 32% Poorly correlated | +0.53% | ||
More |